Anti-Inflammatory Therapeutics
SKU
MRR-5C6F41F5B03B
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 101.53 billion
2030
USD 142.21 billion
2024
USD 103.85 billion
CAGR
4.93%
Anti-Inflammatory Therapeutics Market by Drug Class (Anti-inflammatory Biologics, Corticosteroids, Non-steroidal Anti-inflammatory Drugs (NSAIDs)), Indication (Anti-inflammatory Bowel Disease, Arthritis, Multiple Sclerosis), Application - Global Forecast 2024-2030

[191 Pages Report] The Anti-Inflammatory Therapeutics Market size was estimated at USD 101.53 billion in 2023 and expected to reach USD 103.85 billion in 2024, at a CAGR 4.93% to reach USD 142.21 billion by 2030.

Anti-Inflammatory Therapeutics Market
To learn more about this report, request a free sample copy
Anti-inflammatory therapeutics refer to medications or treatments designed to relieve inflammation and alleviate the symptoms associated with conditions, including arthritis, asthma, and autoimmune diseases. These treatments range from nonsteroidal anti-inflammatory drugs (NSAIDs) to corticosteroids and biologics targeting inflammation pathways. The primary drivers include the increasing prevalence of chronic inflammatory diseases, advancements in biologics, and a growing geriatric population susceptible to chronic conditions. Enhanced healthcare infrastructure and heightened patient awareness about disease management also contribute significantly to its need. However, the challenges include the high costs associated with biological treatments and stringent regulatory frameworks that delay product approvals. Potential side effects of long-term use of certain anti-inflammatory drugs also pose significant restraints. One of the primary challenges is the development of drug resistance, particularly in the case of biologics. The patent expiry of blockbuster drugs leading to the influx of generics also poses a substantial challenge, reducing the profitability of innovator companies. Emerging markets represent significant opportunities for expansion due to increasing healthcare expenditure and improving accessibility to advanced treatments. Advances in personalized medicine and drug discovery technologies present opportunities for developing novel anti-inflammatory therapeutics with better efficacy and reduced side effects, catering to unmet medical needs.
Anti-Inflammatory Therapeutics Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Anti-Inflammatory Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anti-Inflammatory Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Anti-Inflammatory Therapeutics Market, highlighting leading vendors and their innovative profiles. These include Abbvie, Inc., Algen Healthcare Ltd., Allegiant Health, Alvogen, Amgen Inc., Amneal Pharmaceuticals LLC, Arcutis Biotherapeutics, Inc., Astellas Pharma Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Clearsynth Labs Limited, Genentech, Inc. by Roche Group, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Kymera Therapeutics, Novartis AG, Pfizer Inc., Pharbest Pharmaceuticals, Inc., Sanofi Group, Spectrum Chemical Mfg. Corp., Sun Pharmaceutical Industries Ltd., and Teikoku Seiyaku Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Anti-Inflammatory Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Anti-inflammatory Biologics
    • Corticosteroids
    • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Indication
    • Anti-inflammatory Bowel Disease
    • Arthritis
    • Multiple Sclerosis
    • Psoriasis
    • Respiratory Disease
  • Application
    • Autoimmune
    • Inflammatory Diseases
    • Respiratory Diseases

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Anti-Inflammatory Therapeutics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anti-Inflammatory Therapeutics Market?
  3. What are the technology trends and regulatory frameworks in the Anti-Inflammatory Therapeutics Market?
  4. What is the market share of the leading vendors in the Anti-Inflammatory Therapeutics Market?
  5. Which modes and strategic moves are suitable for entering the Anti-Inflammatory Therapeutics Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageANTI-INFLAMMATORY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. ANTI-INFLAMMATORY THERAPEUTICS MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
    2. Anti-Inflammatory Therapeutics Market, by RegionANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsANTI-INFLAMMATORY THERAPEUTICS MARKET DYNAMICS
      1. Drivers
        1. High prevalence of chronic disorders globally
        2. Rising availability of biologic drugs for the treatment of inflammatory conditions
        3. Growing government initiatives to expand the awareness of inflammatory therapeutics
      2. Restraints
        1. High cost associated with anti-inflammatory therapeutics
      3. Opportunities
        1. Growing research & development activities to develop anti-inflammatory therapeutics
        2. Rising approval process for anti-inflammatory therapeutics
      4. Challenges
        1. Certain side effects associated with anti-inflammatory therapeutics
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Anti-Inflammatory Therapeutics Market, by Drug Class
    1. IntroductionANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
    2. Anti-inflammatory BiologicsANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY BIOLOGICS, BY , 2018-2030 (USD MILLION)
    3. CorticosteroidsANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY CORTICOSTEROIDS, BY , 2018-2030 (USD MILLION)
    4. Non-steroidal Anti-inflammatory Drugs (NSAIDs)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY , 2018-2030 (USD MILLION)
  7. Anti-Inflammatory Therapeutics Market, by Indication
    1. IntroductionANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
    2. Anti-inflammatory Bowel DiseaseANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY BOWEL DISEASE, BY , 2018-2030 (USD MILLION)
    3. ArthritisANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY ARTHRITIS, BY , 2018-2030 (USD MILLION)
    4. Multiple SclerosisANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY , 2018-2030 (USD MILLION)
    5. PsoriasisANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY PSORIASIS, BY , 2018-2030 (USD MILLION)
    6. Respiratory DiseaseANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY RESPIRATORY DISEASE, BY , 2018-2030 (USD MILLION)
  8. Anti-Inflammatory Therapeutics Market, by Application
    1. IntroductionANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    2. AutoimmuneANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY AUTOIMMUNE, BY , 2018-2030 (USD MILLION)
    3. Inflammatory DiseasesANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY , 2018-2030 (USD MILLION)
    4. Respiratory DiseasesANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY RESPIRATORY DISEASES, BY , 2018-2030 (USD MILLION)
  9. Americas Anti-Inflammatory Therapeutics Market
    1. Introduction
    2. AMERICAS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)AMERICAS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AMERICAS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    3. AMERICAS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)ARGENTINA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ARGENTINA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)BRAZIL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)BRAZIL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)CANADA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CANADA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)MEXICO ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MEXICO ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)UNITED STATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED STATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    14. UNITED STATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  10. Asia-Pacific Anti-Inflammatory Therapeutics Market
    1. Introduction
    2. ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)AUSTRALIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)AUSTRALIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    6. China
    7. CHINA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)CHINA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)CHINA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    8. India
    9. INDIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)INDIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)INDONESIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)INDONESIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)JAPAN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)JAPAN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)MALAYSIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)MALAYSIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)PHILIPPINES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)PHILIPPINES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SINGAPORE ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SINGAPORE ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SOUTH KOREA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH KOREA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)TAIWAN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TAIWAN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)THAILAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)THAILAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)VIETNAM ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)VIETNAM ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  11. Europe, Middle East & Africa Anti-Inflammatory Therapeutics Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)DENMARK ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)DENMARK ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)EGYPT ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)EGYPT ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)FINLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FINLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)FRANCE ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)FRANCE ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)GERMANY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)GERMANY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)ISRAEL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ISRAEL ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)ITALY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)ITALY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)NETHERLANDS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NETHERLANDS ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)NIGERIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NIGERIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)NORWAY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)NORWAY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)POLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)POLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)QATAR ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)QATAR ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)RUSSIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)RUSSIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SAUDI ARABIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SAUDI ARABIA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SOUTH AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SOUTH AFRICA ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SPAIN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SPAIN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SWEDEN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWEDEN ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)SWITZERLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)SWITZERLAND ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)TURKEY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)TURKEY ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)UNITED KINGDOM ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)UNITED KINGDOM ANTI-INFLAMMATORY THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  12. Competitive Landscape
    1. FPNV Positioning MatrixANTI-INFLAMMATORY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023ANTI-INFLAMMATORY THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerANTI-INFLAMMATORY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023ANTI-INFLAMMATORY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
  13. Competitive Portfolio
    1. Key Company Profiles
      1. Abbvie, Inc.
      2. Algen Healthcare Ltd.
      3. Allegiant Health
      4. Alvogen
      5. Amgen Inc.
      6. Amneal Pharmaceuticals LLC
      7. Arcutis Biotherapeutics, Inc.
      8. Astellas Pharma Inc.
      9. AstraZeneca PLC
      10. Bayer AG
      11. Bristol-Myers Squibb Company
      12. Clearsynth Labs Limited
      13. Genentech, Inc. by Roche Group
      14. GlaxoSmithKline PLC
      15. Johnson & Johnson Services, Inc.
      16. Kymera Therapeutics
      17. Novartis AG
      18. Pfizer Inc.
      19. Pharbest Pharmaceuticals, Inc.
      20. Sanofi Group
      21. Spectrum Chemical Mfg. Corp.
      22. Sun Pharmaceutical Industries Ltd.
      23. Teikoku Seiyaku Co., Ltd.
    2. Key Product Portfolio
  1. Abbvie, Inc.
  2. Algen Healthcare Ltd.
  3. Allegiant Health
  4. Alvogen
  5. Amgen Inc.
  6. Amneal Pharmaceuticals LLC
  7. Arcutis Biotherapeutics, Inc.
  8. Astellas Pharma Inc.
  9. AstraZeneca PLC
  10. Bayer AG
  11. Bristol-Myers Squibb Company
  12. Clearsynth Labs Limited
  13. Genentech, Inc. by Roche Group
  14. GlaxoSmithKline PLC
  15. Johnson & Johnson Services, Inc.
  16. Kymera Therapeutics
  17. Novartis AG
  18. Pfizer Inc.
  19. Pharbest Pharmaceuticals, Inc.
  20. Sanofi Group
  21. Spectrum Chemical Mfg. Corp.
  22. Sun Pharmaceutical Industries Ltd.
  23. Teikoku Seiyaku Co., Ltd.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Anti-Inflammatory Therapeutics Market
The Global Anti-Inflammatory Therapeutics Market size was estimated at USD 101.53 billion in 2023 and expected to reach USD 103.85 billion in 2024.
The Global Anti-Inflammatory Therapeutics Market to grow USD 142.21 billion by 2030, at a CAGR of 4.93%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.